SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-18-014380
Filing Date
2018-11-14
Accepted
2018-11-14 17:16:25
Documents
48
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q cpix-20180930.htm   iXBRL 10-Q 889065
2 EX-10.1 cpixq32018-exhibit101.htm EX-10.1 18773
3 EX-31.1 cpixq32018-exhibit311.htm EX-31.1 16319
4 EX-31.2 cpixq32018-exhibit312.htm EX-31.2 16328
5 EX-32.1 cpixq32018-exhibit321.htm EX-32.1 9313
  Complete submission text file 0001628280-18-014380.txt   3382960

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cpix-20180930.xsd EX-101.SCH 21628
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cpix-20180930_cal.xml EX-101.CAL 53079
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cpix-20180930_def.xml EX-101.DEF 85784
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cpix-20180930_lab.xml EX-101.LAB 270043
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cpix-20180930_pre.xml EX-101.PRE 174599
11 EXTRACTED XBRL INSTANCE DOCUMENT cpix-20180930_htm.xml XML 506742
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

IRS No.: 000000000
Type: 10-Q | Act: 34 | File No.: 001-33637 | Film No.: 181185100
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1